Artivila Therapeutics
Artivila Therapeutics uses AI and computational chemistry to discover small-molecule therapeutics for neurodegenerative diseases, cancers, and autoimmune disorders. The company combines machine learning, molecular docking, free-energy calculations and quantum chemistry with tools such as TensorFlow, Python, Autodock, Schrodinger, MOE, Amber and Gaussian to design and prioritize candidate molecules. It operates as a pharmaceutical drug-discovery organization that partners with biopharma and advances leads through in-house preclinical development. The platform integrates cheminformatics, bioinformatics and data-modeling pipelines to accelerate hit identification and lead optimization. Artivila targets global therapeutic markets seeking novel small-molecule and first-in-class assets.
Artivila Therapeutics
Artivila Therapeutics uses AI and computational chemistry to discover small-molecule therapeutics for neurodegenerative diseases, cancers, and autoimmune disorders. The company combines machine learning, molecular docking, free-energy calculations and quantum chemistry with tools such as TensorFlow, Python, Autodock, Schrodinger, MOE, Amber and Gaussian to design and prioritize candidate molecules. It operates as a pharmaceutical drug-discovery organization that partners with biopharma and advances leads through in-house preclinical development. The platform integrates cheminformatics, bioinformatics and data-modeling pipelines to accelerate hit identification and lead optimization. Artivila targets global therapeutic markets seeking novel small-molecule and first-in-class assets.